Review

. 2024 Jul;20(7):5009-5026.

doi: 10.1002/alz.13850. Epub 2024 May 27.

Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City

Ana Luisa Sosa¹, Sonia Md Brucki², Lucia Crivelli³, Francisco Javier Lopera⁴, Daisy M Acosta⁵, Juliana Acosta-Uribe^{4

6}, Diego Aguilar⁷, Sara G Aguilar-Navarro⁸, Ricardo F Allegri^{9

10}, Paulo Hf Bertolucci¹¹, Ismael L Calandri³, Maria C Carrillo¹², Patricio Alexis Chrem Mendez¹³, Mario Cornejo-Olivas^{14

15}, Nilton Custodio^{16

17}, Andrés Damian¹⁸, Leonardo Cruz de Souza^{19

20}, Claudia Duran-Aniotz^{21

22}, Adolfo M García^{21

23

24

25}, Carmen García-Peña²⁶, Mitzi M Gonzales^{27

28}, Lea T Grinberg^{29

30}, Agustin M Ibanez^{21

23

31

32

33}, Maryenela Zaida Illanes-Manrique^{14

15

23}, Clifford R Jack Jr³⁴, Jorge Mario Leon-Salas³⁵, Jorge J Llibre-Guerra^{36

37}, José Luna-Muñoz^{38

39

40}, Diana Matallana^{41

42

43}, Bruce L Miller^{23

44}, Lorina Naci^{31

45}, Mario A Parra⁴⁶, Margaret Pericak-Vance^{47

48}, Stefanie D Piña-Escudero^{23

31

44}, Elisa de Paula França Resende^{23

31

49}, John M Ringman⁵⁰, Gustavo Sevlever⁵¹, Andrea Slachevsky^{52

53

54

55}, Claudia Kimie Suemoto⁵⁶, Victor Valcour⁵⁷, Andres Villegas-Lanau⁴, Mônica S Yassuda^{2

58}, Simin Mahinrad¹², Claire Sexton¹²

Affiliations

¹ Laboratorio de Demencias del Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, CDMX, México.
² Department of Neurology, Cognitive and Behavioral Group, University of Sao Paulo, São Paulo, São Paulo, Brazil.
³ Department of Cognitive Neurology, Fleni, Buenos Aires, Argentina.
⁴ Grupo de Neurociencias (GNA), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
⁵ Universidad Nacional Pedro Henriquez Urena (UNPHU), Santo Domingo, Dominican Republic.
⁶ Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, USA.
⁷ Alzheimer's Disease International, London, UK.
⁸ Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, México, CDMX, Mexico.
⁹ Instituto de Neurociencias, Fleni, Buenos Aires, Argentina.
¹⁰ Department of Neurosciences, Universidad de la Costa CUC, Barranquilla, Colombia.
¹¹ Neurology & Neurosurgery Department, Escola Paulista de Medicina/UNIFESP, São Paulo, São Paulo, Brazil.
¹² Alzheimer's Association, Chicago, Illinois, USA.
¹³ Memory Center, Fleni, Buenos Aires, Argentina.
¹⁴ Neurogenetics Working Group, Universidad Científica del Sur, Lima, Peru.
¹⁵ Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
¹⁶ Unidad de Diagnóstico de Deterioro Cognitivo y Prevención de Demencia, Instituto Peruano de Neurociencias, Lima, Peru.
¹⁷ Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru.
¹⁸ Departamento de Montevideo, Centro Uruguayo de Imagenología Molecular (CUDIM) and Unidad Académica de Medicina Nuclear e Imagenología Molecular, Hospital de Clínicas, Universidad de la República (UdelaR), Montevideo, Montevideo, Uruguay.
¹⁹ Programa de Pós-Graduação em Neurociências, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
²⁰ Departamento de Clínica Médica da Faculdade de Medicina da UFMG, Belo Horizonte, MG, Brazil.
²¹ Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibañez, Santiago, Chile.
²² Center for Social and Cognitive Neuroscience (CSCN), School of Psychology, Universidad Adolfo Ibañez, Santiago, Chile.
²³ Global Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
²⁴ Cognitive Neuroscience Center, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
²⁵ Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago, Chile.
²⁶ Instituto Nacional de Geriatría, México, CDMX, Mexico.
²⁷ Department of Neurology, Cedars Sinai Medical Center, Los Angeles, California, USA.
²⁸ Glenn Biggs Institute, UT Health San Antonio, San Antonio, Texas, USA.
²⁹ Department of Neurology and Pathology, University of California San Francisco (UCSF), San Francisco, California, USA.
³⁰ Department of Pathology, University of Sao Paulo, São Paulo, São Paulo, Brazil.
³¹ Global Brain Health Institute (GBHI), University of Trinity Dublin, Lloyd Building Trinity College Dublin, Dublin, Ireland.
³² Cognitive Neuroscience Center (CNC), Universidad de San Andrés, and CONICET, Victoria, Argentina.
³³ Trinity College Dublin (TCD), College Green, Dublin, Ireland.
³⁴ Mayo Clinic, Rochester, Minnesota, USA.
³⁵ Departamento de Investigación Clínica, Life Science Research Institute, Hospital Clinica Biblica, San José, Costa Rica.
³⁶ Dominantly Inherited Alzheimer's Network Trials Unit, Washington University School of Medicine, St. Louis, Missouri, USA.
³⁷ Department of Neurology, Washington University School of Medicine in St.Louis, St. Louis, Missouri, USA.
³⁸ Banco Nacional de Cerebros-UNPHU, Universidad Nacional Pedro Henríquez Ureña, Santo Domingo, Dominican Republic.
³⁹ National Dementia BioBank, Dirección de Investigación, Innovación y Posgrado, Universidad Politécnica de Pachuca, Zempoala, México.
⁴⁰ Federación Mexicana de Alzheimer (FEDMA), México, CDMX, Mexico.
⁴¹ Pontificia Universidad Javeriana, Medical School, Aging Institute, Hospital Universitario San Ignacio, Bogotá, Colombia.
⁴² Memory and Cognition Center, Intellectus, Hospital Universitario San Ignacio, Bogotá, Colombia.
⁴³ Mental Health Department, Hospital Universitario Fundación Santa Fe, Bogotá, Colombia.
⁴⁴ Department of Neurology, Memory and Aging Center, University of California San Francisco (UCSF), San Francisco, California, USA.
⁴⁵ Trinity College Institute of Neuroscience, Trinity College Dublin, College Green, Dublin, Ireland.
⁴⁶ Department of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.
⁴⁷ John P Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Coral Gables, Florida, USA.
⁴⁸ Dr. John T Macdonald Foundation, Department of Human Genetics, University of Miami Miller School of Medicine, Coral Gables, Florida, USA.
⁴⁹ Universidade Federal de Minas Gerais, Faculdade de Medicina Ciências Médicas de Minas Gerais, Hospital das Clínicas - EBSERH-UFMG, Belo Horizonte, Brazil.
⁵⁰ Department of Neurology, Alzheimer's Disease Research Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
⁵¹ Department of Neuropathology, Fleni, Buenos Aires, Argentina.
⁵² Geroscience Center for Brain Health and Metabolism (GERO), Santiago, Chile.
⁵³ Memory and Neuropsychiatric Center (CMYN), Neurology Department, Hospital del Salvador & Faculty of Medicine, University of Chile, Santiago de Chile, Chile.
⁵⁴ Neuropsychology and Clinical Neuroscience Laboratory (LANNEC), Physiopathology Program - Institute of Biomedical Sciences (ICBM), Neuroscience and East Neuroscience Departments, Faculty of Medicine, University of Chile, Santiago de Chile, Chile.
⁵⁵ Servicio de Neurología, Departamento de Medicina, Clínica Alemana-Universidad del Desarrollo, Las Condes, Chile.
⁵⁶ Division of Geriatrics, University of Sao Paulo Medical School, São Paulo, São Paulo, Brazil.
⁵⁷ Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA.
⁵⁸ Gerontology, School of Arts, Sciences and Humanities, University of Sao Paulo, São Paulo, São Paulo, Brazil.

PMID: 38801124
PMCID: PMC11247679
DOI: 10.1002/alz.13850

Review

Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City

Ana Luisa Sosa et al. Alzheimers Dement. 2024 Jul.

. 2024 Jul;20(7):5009-5026.

doi: 10.1002/alz.13850. Epub 2024 May 27.

Authors

Affiliations

¹ Laboratorio de Demencias del Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, CDMX, México.
² Department of Neurology, Cognitive and Behavioral Group, University of Sao Paulo, São Paulo, São Paulo, Brazil.
³ Department of Cognitive Neurology, Fleni, Buenos Aires, Argentina.
⁴ Grupo de Neurociencias (GNA), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
⁵ Universidad Nacional Pedro Henriquez Urena (UNPHU), Santo Domingo, Dominican Republic.
⁶ Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, USA.
⁷ Alzheimer's Disease International, London, UK.
⁸ Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, México, CDMX, Mexico.
⁹ Instituto de Neurociencias, Fleni, Buenos Aires, Argentina.
¹⁰ Department of Neurosciences, Universidad de la Costa CUC, Barranquilla, Colombia.
¹¹ Neurology & Neurosurgery Department, Escola Paulista de Medicina/UNIFESP, São Paulo, São Paulo, Brazil.
¹² Alzheimer's Association, Chicago, Illinois, USA.
¹³ Memory Center, Fleni, Buenos Aires, Argentina.
¹⁴ Neurogenetics Working Group, Universidad Científica del Sur, Lima, Peru.
¹⁵ Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
¹⁶ Unidad de Diagnóstico de Deterioro Cognitivo y Prevención de Demencia, Instituto Peruano de Neurociencias, Lima, Peru.
¹⁷ Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru.
¹⁸ Departamento de Montevideo, Centro Uruguayo de Imagenología Molecular (CUDIM) and Unidad Académica de Medicina Nuclear e Imagenología Molecular, Hospital de Clínicas, Universidad de la República (UdelaR), Montevideo, Montevideo, Uruguay.
¹⁹ Programa de Pós-Graduação em Neurociências, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
²⁰ Departamento de Clínica Médica da Faculdade de Medicina da UFMG, Belo Horizonte, MG, Brazil.
²¹ Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibañez, Santiago, Chile.
²² Center for Social and Cognitive Neuroscience (CSCN), School of Psychology, Universidad Adolfo Ibañez, Santiago, Chile.
²³ Global Brain Health Institute (GBHI), University of California San Francisco (UCSF), San Francisco, California, USA.
²⁴ Cognitive Neuroscience Center, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
²⁵ Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago, Chile.
²⁶ Instituto Nacional de Geriatría, México, CDMX, Mexico.
²⁷ Department of Neurology, Cedars Sinai Medical Center, Los Angeles, California, USA.
²⁸ Glenn Biggs Institute, UT Health San Antonio, San Antonio, Texas, USA.
²⁹ Department of Neurology and Pathology, University of California San Francisco (UCSF), San Francisco, California, USA.
³⁰ Department of Pathology, University of Sao Paulo, São Paulo, São Paulo, Brazil.
³¹ Global Brain Health Institute (GBHI), University of Trinity Dublin, Lloyd Building Trinity College Dublin, Dublin, Ireland.
³² Cognitive Neuroscience Center (CNC), Universidad de San Andrés, and CONICET, Victoria, Argentina.
³³ Trinity College Dublin (TCD), College Green, Dublin, Ireland.
³⁴ Mayo Clinic, Rochester, Minnesota, USA.
³⁵ Departamento de Investigación Clínica, Life Science Research Institute, Hospital Clinica Biblica, San José, Costa Rica.
³⁶ Dominantly Inherited Alzheimer's Network Trials Unit, Washington University School of Medicine, St. Louis, Missouri, USA.
³⁷ Department of Neurology, Washington University School of Medicine in St.Louis, St. Louis, Missouri, USA.
³⁸ Banco Nacional de Cerebros-UNPHU, Universidad Nacional Pedro Henríquez Ureña, Santo Domingo, Dominican Republic.
³⁹ National Dementia BioBank, Dirección de Investigación, Innovación y Posgrado, Universidad Politécnica de Pachuca, Zempoala, México.
⁴⁰ Federación Mexicana de Alzheimer (FEDMA), México, CDMX, Mexico.
⁴¹ Pontificia Universidad Javeriana, Medical School, Aging Institute, Hospital Universitario San Ignacio, Bogotá, Colombia.
⁴² Memory and Cognition Center, Intellectus, Hospital Universitario San Ignacio, Bogotá, Colombia.
⁴³ Mental Health Department, Hospital Universitario Fundación Santa Fe, Bogotá, Colombia.
⁴⁴ Department of Neurology, Memory and Aging Center, University of California San Francisco (UCSF), San Francisco, California, USA.
⁴⁵ Trinity College Institute of Neuroscience, Trinity College Dublin, College Green, Dublin, Ireland.
⁴⁶ Department of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.
⁴⁷ John P Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Coral Gables, Florida, USA.
⁴⁸ Dr. John T Macdonald Foundation, Department of Human Genetics, University of Miami Miller School of Medicine, Coral Gables, Florida, USA.
⁴⁹ Universidade Federal de Minas Gerais, Faculdade de Medicina Ciências Médicas de Minas Gerais, Hospital das Clínicas - EBSERH-UFMG, Belo Horizonte, Brazil.
⁵⁰ Department of Neurology, Alzheimer's Disease Research Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
⁵¹ Department of Neuropathology, Fleni, Buenos Aires, Argentina.
⁵² Geroscience Center for Brain Health and Metabolism (GERO), Santiago, Chile.
⁵³ Memory and Neuropsychiatric Center (CMYN), Neurology Department, Hospital del Salvador & Faculty of Medicine, University of Chile, Santiago de Chile, Chile.
⁵⁴ Neuropsychology and Clinical Neuroscience Laboratory (LANNEC), Physiopathology Program - Institute of Biomedical Sciences (ICBM), Neuroscience and East Neuroscience Departments, Faculty of Medicine, University of Chile, Santiago de Chile, Chile.
⁵⁵ Servicio de Neurología, Departamento de Medicina, Clínica Alemana-Universidad del Desarrollo, Las Condes, Chile.
⁵⁶ Division of Geriatrics, University of Sao Paulo Medical School, São Paulo, São Paulo, Brazil.
⁵⁷ Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA.
⁵⁸ Gerontology, School of Arts, Sciences and Humanities, University of Sao Paulo, São Paulo, São Paulo, Brazil.

PMID: 38801124
PMCID: PMC11247679
DOI: 10.1002/alz.13850

Abstract

Introduction: While Latin America (LatAm) is facing an increasing burden of dementia due to the rapid aging of the population, it remains underrepresented in dementia research, diagnostics, and care.

Methods: In 2023, the Alzheimer's Association hosted its eighth satellite symposium in Mexico, highlighting emerging dementia research, priorities, and challenges within LatAm.

Results: Significant initiatives in the region, including intracountry support, showcased their efforts in fostering national and international collaborations; genetic studies unveiled the unique genetic admixture in LatAm; researchers conducting emerging clinical trials discussed ongoing culturally specific interventions; and the urgent need to harmonize practices and studies, improve diagnosis and care, and use affordable biomarkers in the region was highlighted.

Discussion: The myriad of topics discussed at the 2023 AAIC satellite symposium highlighted the growing research efforts in LatAm, providing valuable insights into dementia biology, genetics, epidemiology, treatment, and care.

Keywords: Alzheimer's disease; Hispanics; Latin America; biomarkers; dementia; genetics.

PubMed Disclaimer

Conflict of interest statement

S. Mahinrad, C. E. Sexton, and M. C. Carrillo are full‐time employees of the Alzheimer's Association. A. L. Sosa reports receiving in the past 36 months consulting fees from Grupo Toscana; receiving payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing, or education events from Aphopharma, Biogen, Carnot, and Lundbeck; and participating in a data safety monitoring board or advisory board of Roche. S. M. D. Brucki reports receiving in the past 36 months consulting fees from Biogen and Roche; payment for lectures at Aché Pharmaceuticals and Novo Nordisk; and support from Novo Nordisk to attend meetings. L Crivelli reports receiving in the past 36 months reimbursement for travel expenses as a member of the Scientific Program Committee to attend AAIC Satellite Mexico 2023, AAIC Amsterdam 2023, and as part of the IMPACT‐AD fellowship from Alzheimer's Association and IMPACT‐AD. F. J. Lopera reports receiving in the past 36 months fees for consulting to Dr. Joseph Arboleda in the Alzheimer's Resistance program, receiving patent Antibody APOE3Ch, and participating on the advisory board of VIEW MIND. D. Acosta reports receiving in the past 36 months support for attending the 2023 AAIC Satellite Symposium in Mexico. J. A. Uribe reports receiving in the past 36 months payment or honoraria from Cajal Neuroscience and Regeneron and support for attending meetings from the University of California Santa Barbara and Rainwater Charitable Foundation. P. H. F. Bertolucci reports receiving in the past 36 months consulting fees from Novo Nordisk, Knight Laboratories, and Support‐Danone; payment from Novo Nordisk for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events; and support from Novo Nordisk for attending meetings. I. L. Calandri reports receiving in the past 36 months support from the Alzheimer's Association to attend AAIC Satellite Mexico 2023. M. C‐Olivas reports receiving in the past 36 months payment or honoraria from MDS for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events; support from National Institutes of Health (NIH) subcontract and ASAP/GP2/MJF for attending meetings; and serving on the MDS‐PAS Executive Committee and as regional mentor for GBHI Fellowship and President of Rare Disorders National Board. N. Custodio reports receiving support to attend the AAIC Satellite Symposium, Mexico 2023. A. Damian reports receiving support to attend the AAIC Satellite Symposium Mexico 2023. L. C. de Souza reports receiving in the past 36 months payment for the development of continuing medical education material and participation as a speaker in symposia sponsored by Biogen and Abbott and payment for serving on the advisory board for Biogen and Lilly. M. García reports receiving financial support from TELL SA and receiving support from Alzheimer's Association to attend AAIC Satellite Mexico 2023. M. M. Gonzales reports having personal stock in AbbVie. L. T. Grinberg reports receiving in the past 36 months consulting fees from Guidepoint Global Inc.; receiving payment or honoraria from Medscape Inc. and Celdare Medical for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events; receiving support for attending meetings and/or travel from the Alzheimer's Association and BrightFocus Foundation; and serving in leadership or fiduciary roles in Global Brain Health Institute. M. Z. I‐M. reports receiving in the past 36 months support for attending meetings and/or travel from the Alzheimer's Association and Global Brain Health Institute. J. M. Leon‐Salas reports receiving in the past 36 months support for attending meetings and/or travel from the Alzheimer's Association. B. L. Miller reports receiving in the past 36 months payments for royalties or licenses from Cambridge University Press, Elsevier, Inc., Guilford Publications, Inc., Johns Hopkins Press, Oxford University Press, and Taylor & Francis Group; consulting fees from Massachusetts General Hospital Alzheimer's Disease Research Center (ADRC) Scientific Advisory Board (SAB), Stanford University ADRC SAB, University of Washington ADRC SAB, and Genworth Medical Advisory Board; receiving payments from the Institute for Lifelong Learning, Global Summit on Neurodegenerative Diseases, Korean Dementia Society, Massachusetts General Hospital, dementia course, National MS Society, Don Paty Lectureship, Ochsner Neuroscience Institute, Providence Saint Joseph Medical Center, Taipei Medical University, Dementia Center, UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), University of California, Los Angeles (UCLA) Grand Round, University of Texas, and Center for Brain Health for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events; receiving support for attending meetings and/or travel from the Association for Frontotemporal Degeneration (AFTD) Education Symposium, St. Louis, MO, Milken Institute FTD Scientific Retreat, Los Angeles, CA, California Institute of the Arts, Los Angeles, CA, and UCLA; serving on a Data Safety Monitoring Board or Advisory Board of Arizona Alzheimer's Consortium, Association for Frontotemporal Degeneration, The Buck Institute for Research on Aging, Cure ALS, The John Douglas French Alzheimer's Foundation, Fundación Centro de Investigación Enfermedades Neurológicas, Madrid, Spain, Genworth, The Larry L. Hillblom Foundation, Massachusetts General Hospital ADRC, National Institute for Health Research Cambridge Biomedical Research Center and its subunit, the Biomedical Research Unit in Dementia, Stanford University ADRC, University of Southern California P01 Urban Air Pollution and Alzheimer's Disease: Risk, Heterogeneity, and Mechanisms, and University of Washington ADR; having a leadership or fiduciary role in the Bluefield Project to Cure FTD, Global Brain Health Institute, Institute for Neurodegenerative Diseases and Tau Consortium of the Rainwater Charitable Fdtn. L. Naci reports receiving in the past 36 months support from the Global Brain Health Institute for attending meetings and/or travel. M. A. Parra reports receiving in the past 36 months consulting fees from ViewMind. E. D. P. F. Resende reports receiving consulting fees from United Medical Ltda in 2021, payment or honoraria from Proneuro, NovoNordisk, and Roche for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events; receiving support for attending meetings and/or travel from the Alzheimer's Association; serving as the deputy chair of the Scientific Department for Behavioral Neurology and Aging at the Brazilian Academy of Neurology. J. M. Ringman reports receiving in the past 36 months consulting fees from Eisai Pharmaceuticals, payments from PriMed CME/CE organization for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events; support from the Alzheimer's Association to attend the AAIC Satellite Mexico 2023; and doses of flortaucipir for research from Avid Pharmaceuticals. G. Sevlever reports receiving support for attending meetings and/or travel from Fleni, Buenos Aires, Argentina. A. Slachevsky reports receiving support from the Alzheimer's Association and GBHI for attending meetings and/or travel and having a leadership or fiduciary role on the board of Global Brain Health Institute. C. K. Suemoto reports receiving a travel fellowship from the Alzheimer's Association to attend the 2023 AAIC Satellite Symposium and serving on the ISTAART advisory council and in Brazilian Society of Geriatrics and Gerontology. V. Valcour reports receiving payment or honoraria from IAS‐USA for providing CME; and support from the Atlantic Philanthropies for attending meetings and/or travel. M. S. Yassuda reports payment or honoraria from Supera – Brazilian Company and Institute of Neurology – BRAIN Congress in Brazil for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events amd support from Brazilian National Council for Scientific and Technological Development and the Alzheimer´s Association to attend AAIC in Mexico.

The remaining authors have nothing to declare. Author disclosures are available in the supporting information.

Cited by

Lewy Body Dementia Research in Latin America: A Scoping Review.
Cano-Gutiérrez C, Salazar-Londoño S, Botero-Rodriguez F, Páez-García S, Giraldo S, Santacruz-Escudero JM, Aarsland D, Borda MG; COL‐DLB. Cano-Gutiérrez C, et al. Mov Disord Clin Pract. 2025 Aug;12(8):1053-1065. doi: 10.1002/mdc3.70059. Epub 2025 Apr 21. Mov Disord Clin Pract. 2025. PMID: 40256832 Free PMC article.
Driving research on successful aging and neuroprotection in Latin America: Insights from the inaugural symposium on brain resilience and healthy longevity.
Quiroz YT, Aguillón D, Arboleda-Velasquez J, Bocanegra Y, Cardona-Gómez GP, Corrada MM, Diez I, Garcia-Cifuentes E, Kosik K, Martinez L, Pineda-Salazar D, Posada R, Roman N, Sepulveda-Falla D, Slachevsky A, Soto-Añari M, Tabilo E, Vasquez D, Villegas-Lanau A. Quiroz YT, et al. Alzheimers Dement. 2025 Mar;21(3):e70037. doi: 10.1002/alz.70037. Alzheimers Dement. 2025. PMID: 40145291 Free PMC article. Review.
Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990-2021: A systematic analysis for the Global Burden of Disease study 2021.
Wang F, Li D, Gao X, Zhang X, Shi X, Guo Y. Wang F, et al. Alzheimers Dement (Amst). 2025 May 27;17(2):e70126. doi: 10.1002/dad2.70126. eCollection 2025 Apr-Jun. Alzheimers Dement (Amst). 2025. PMID: 40438037 Free PMC article.
Need to adapt Alzheimer's disease criteria in Latin America.
Custodio N, Allegri R, Lopera F, Caramelli P. Custodio N, et al. Alzheimers Dement. 2024 Nov;20(11):8206-8208. doi: 10.1002/alz.14289. Epub 2024 Oct 6. Alzheimers Dement. 2024. PMID: 39369281 Free PMC article. No abstract available.

References

1. 2023 Alzheimer's disease facts and figures. Alzheimers Dement. 2023;19:1598‐1695. doi: 10.1002/alz.13016 PMID:36918389 - DOI - PubMed
1. Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time. Pan American Health Organization; 2023. doi: 10.37774/9789275126653 - DOI
1. Prince M, Acosta D, Ferri CP, et al. Dementia incidence and mortality in middle‐income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population‐based cohort study. Lancet Lond Engl. 2012;380:50‐58. doi: 10.1016/S0140-6736(12)60399-7 - DOI - PMC - PubMed
1. Ibáñez A, Pina‐Escudero SD, Possin KL, et al. Dementia caregiving across Latin America and the Caribbean and brain health diplomacy. Lancet Healthy Longev. 2021;2:e222‐e231. doi: 10.1016/S2666-7568(21)00031-3 - DOI - PMC - PubMed
1. Parra MA, Baez S, Sedeño L, et al. Dementia in Latin America: paving the way toward a regional action plan. Alzheimers Dement J Alzheimers Assoc. 2021;17:295‐313. doi: 10.1002/alz.12202 - DOI - PMC - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City

Affiliations

Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical